阿卡波糖雜質(zhì)Ⅳ: 4-O-[4,6-雙去氧-4-[[(1S,4R,5S,6S)-4,5,6-三羥基-3-(羥基甲基)環(huán)己烯-2-基]氨基]-α-D-吡喃葡糖基]-D-吡喃葡糖
|
PCL-#-Chp0191-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
PCL-#-Chp0191-N/A |
50mg
|
咨詢
|
咨詢 |
PCL |
阿卡波糖雜質(zhì)Ⅳ: 4-O-[4,6-雙去氧-4-[[(1S,4R,5S,6S)-4,5,6-三羥基-3-(羥基甲基)環(huán)己烯-2-基]氨基]-α-D-吡喃葡糖基]-D-吡喃葡糖
|
PCL-#-Chp0191-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
PCL-#-Chp0191-N/A |
25mg
|
咨詢
|
咨詢 |
PCL |
阿卡波糖雜質(zhì)Ⅲ: α-D-吡喃葡糖基,4-O-[4,6-雙去氧-4-[[(1S,4R,5S,6S)-4,5,6-三羥基-3-(羥基甲基)環(huán)己烯-2-基]氨基]-α-D-吡喃葡糖基]-α-D-吡喃葡萄糖苷
|
PCL-#-Chp0190-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
1013621-79-8 |
50mg
|
咨詢
|
咨詢 |
PCL |
阿卡波糖雜質(zhì)Ⅲ: α-D-吡喃葡糖基,4-O-[4,6-雙去氧-4-[[(1S,4R,5S,6S)-4,5,6-三羥基-3-(羥基甲基)環(huán)己烯-2-基]氨基]-α-D-吡喃葡糖基]-α-D-吡喃葡萄糖苷
|
PCL-#-Chp0190-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
1013621-79-8 |
25mg
|
咨詢
|
咨詢 |
PCL |
阿卡波糖雜質(zhì)Ⅱ:(1R,4R,5S,6S)-4,5,6-三羥基-2-(羥基甲基)環(huán)己烯-2-基,4-O-[4,6-雙去氧-4-[[(1S,4R,5S,6S)-4,5,6-三羥基-3-(羥基甲基)環(huán)己烯-2-基]氨基]-α-D-吡喃葡糖基]-α-D-吡喃葡糖苷
|
PCL-#-Chp0189-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
PCL-#-Chp0189-N/A |
50mg
|
咨詢
|
咨詢 |
PCL |
阿卡波糖雜質(zhì)Ⅱ:(1R,4R,5S,6S)-4,5,6-三羥基-2-(羥基甲基)環(huán)己烯-2-基,4-O-[4,6-雙去氧-4-[[(1S,4R,5S,6S)-4,5,6-三羥基-3-(羥基甲基)環(huán)己烯-2-基]氨基]-α-D-吡喃葡糖基]-α-D-吡喃葡糖苷
|
PCL-#-Chp0189-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
PCL-#-Chp0189-N/A |
25mg
|
咨詢
|
咨詢 |
PCL |
阿卡波糖雜質(zhì)Ⅰ: O-4,6-雙去氧-4-[[(1S,4R,5S,6S)-4,5,6-三羥基-3-(羥基甲基)環(huán)己烯-2-基]氨基]-α-D-吡喃葡糖基-(1→4)-O-α-D-吡喃葡糖基-(1→4)-D-吡喃阿拉伯糖
|
PCL-#-Chp0188-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
56180-94-0 |
50mg
|
咨詢
|
咨詢 |
PCL |
阿卡波糖雜質(zhì)Ⅰ: O-4,6-雙去氧-4-[[(1S,4R,5S,6S)-4,5,6-三羥基-3-(羥基甲基)環(huán)己烯-2-基]氨基]-α-D-吡喃葡糖基-(1→4)-O-α-D-吡喃葡糖基-(1→4)-D-吡喃阿拉伯糖
|
PCL-#-Chp0188-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
56180-94-0 |
25mg
|
咨詢
|
咨詢 |
PCL |
L-焦谷氨酸
|
PCL-#-Chp0187-50mg
|
≥95% ,雜質(zhì)對(duì)照品 |
98-79-3 |
50mg
|
¥ 300.0
|
3-5天 |
PCL |
L-焦谷氨酸
|
PCL-#-Chp0187-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
98-79-3 |
25mg
|
咨詢
|
咨詢 |
PCL |
谷氨酰胺雜質(zhì)Ⅰ 谷氨酸
|
PCL-#-Chp0186-50mg
|
≥95%,雜質(zhì)對(duì)照品 |
56-86-0 |
50mg
|
咨詢
|
現(xiàn)貨 |
PCL |
谷氨酰胺雜質(zhì)Ⅰ 谷氨酸
|
PCL-#-Chp0186-25mg
|
≥95% ,雜質(zhì)對(duì)照品 |
56-86-0 |
25mg
|
¥ 600.0
|
3-5天 |
PCL |
佐米曲普坦雜質(zhì)A( R-佐米曲普坦)
|
PCL-#-Chp0185-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
139264-24-7 |
50mg
|
¥ 12000.0
|
1-2周 |
PCL |
佐米曲普坦雜質(zhì)A( R-佐米曲普坦)
|
PCL-#-Chp0185-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
139264-24-7 |
25mg
|
¥ 6000.0
|
咨詢 |
PCL |
利福昔明雜質(zhì)B(2S,20S,21S,22R,23R,24R,25S,26R,27S)-5,21,23-三羧基-27-甲氧基-2,4,16,20,22,24,26-七甲基-11-亞甲基-1,6,15-三氧代-1,2,6,11-四氫化-2,7-(環(huán)氧十五[1,11,13]三烯醇亞胺)呋喃[2〞,3〞:7’,8’]萘[1,2’:4,5]咪唑[1,2-α]吡啶-25-基-醋酸
|
PCL-#-Chp0184-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
1351775-03-5 |
50mg
|
咨詢
|
咨詢 |
PCL |
利福昔明雜質(zhì)B(2S,20S,21S,22R,23R,24R,25S,26R,27S)-5,21,23-三羧基-27-甲氧基-2,4,16,20,22,24,26-七甲基-11-亞甲基-1,6,15-三氧代-1,2,6,11-四氫化-2,7-(環(huán)氧十五[1,11,13]三烯醇亞胺)呋喃[2〞,3〞:7’,8’]萘[1,2’:4,5]咪唑[1,2-α]吡啶-25-基-醋酸
|
PCL-#-Chp0184-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
1351775-03-5 |
25mg
|
咨詢
|
咨詢 |
PCL |
利福昔明雜質(zhì)A(2S,20S,21S,22R,23R,24R,25S,26R,27S)-6,21,23-三羧基-27-甲氧基-2,4,16,20,22,24,26-七甲基-11-亞甲基-1,5,15-三氧代-1,2,5,11-四氫化-2,7-(環(huán)氧十五[1,11,13]三烯醇亞胺)呋喃[2〞,3〞:7’,8’]萘[1’,2’、:4,5]咪唑[l,2-α]吡啶-25-基-醋酸
|
PCL-#-Chp0183-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
1351775-04-6 |
50mg
|
咨詢
|
咨詢 |
PCL |
利福昔明雜質(zhì)A(2S,20S,21S,22R,23R,24R,25S,26R,27S)-6,21,23-三羧基-27-甲氧基-2,4,16,20,22,24,26-七甲基-11-亞甲基-1,5,15-三氧代-1,2,5,11-四氫化-2,7-(環(huán)氧十五[1,11,13]三烯醇亞胺)呋喃[2〞,3〞:7’,8’]萘[1’,2’、:4,5]咪唑[l,2-α]吡啶-25-基-醋酸
|
PCL-#-Chp0183-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
1351775-04-6 |
25mg
|
咨詢
|
咨詢 |
PCL |
利福平雜質(zhì)Ⅳ N-氧化利福平
|
PCL-#-Chp0182-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
125833-03-6 |
50mg
|
咨詢
|
咨詢 |
PCL |
利福平雜質(zhì)Ⅳ N-氧化利福平
|
PCL-#-Chp0182-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
125833-03-6 |
25mg
|
咨詢
|
咨詢 |
PCL |
利福平雜質(zhì)Ⅲ 醌式利福平
|
PCL-#-Chp0181-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
13983-13-6 |
50mg
|
咨詢
|
咨詢 |
PCL |
利福平雜質(zhì)Ⅲ 醌式利福平
|
PCL-#-Chp0181-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
13983-13-6 |
25mg
|
咨詢
|
咨詢 |
PCL |
利福平雜質(zhì)Ⅱ 利福霉素SV
|
PCL-#-Chp0180-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
6998-60-3 |
50mg
|
咨詢
|
咨詢 |
PCL |
利福平雜質(zhì)Ⅱ 利福霉素SV
|
PCL-#-Chp0180-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
6998-60-3 |
25mg
|
咨詢
|
咨詢 |
PCL |